A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by Ben-Gurion University of the Negev (BGU).
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors including...
